Cardiawave logo — Cardiawave is developing an innovative and non-invasive ultr...

Cardiawave

Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis.

Founded 2014 France France 33 employees Grant Total: $13.31M Health Care, Medical Devices

General Information

Company Name Cardiawave
Founded Year 2014
Location France France +1
Employees 33
Industries Health Care, Medical Devices
Funding Stage Grant
Social

Get notified when Cardiawave moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cardiawave

Cardiawave is a clinical-stage company founded in 2014 and based in France, aiming to combat aortic valve stenosis, a life-threatening condition affecting approximately 10 million people in Western countries. The company has attracted attention by winning multiple innovation prizes and is backed by a significant €3.56MGrant investment from EASME - EU Executive Agency for SMEs as of 01 January 2019. Cardiawave has partnered with esteemed institutions such as the Langevin Institute \/ Physics for Medicine Paris and the Georges Pompidou European Hospital (HEGP) to develop a groundbreaking non-invasive image-guided medical device (MD) that employs focused ultrasound therapy to soften aortic valve leaflets and improve valve opening. This innovative approach holds tremendous promise in addressing a condition that poses a major public health concern. With its strong strategic alliances and pioneering technology, Cardiawave positions itself as a key player in revolutionizing treatment methodologies within the Health Care industry.

Taxonomy: medical device, non-invasive treatment, aortic valve stenosis, ultrasound therapy, clinical-stage startup, innovative technology, image-guided therapy, Langevin Institute, Georges Pompidou European Hospital, cardiovascular health, award-winning, partnership, biomedical engineering

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 01 Jan 2019
Venture Round •••••• 6
Investor Investor Investor Investor
•••• ••••
27 Sep 2018
Venture Round •••••• 5
Investor Investor Investor
•••• ••••
02 Mar 2017
Seed Round •••••• 1
Investor
01 Dec 2015
Pre Seed Round •••••• 1
Investor
21 May 2015

View All 6 Funding Rounds

Cardiawave Alternatives & Competitors

Cardiawave vs

Thubrikar Aortic Valve is a privately held medical device company on a mission to revolutionize the...

Angel
4 employees
Health Care, Medical Devices
Cardiawave vs

Anteris Technologies is a structural heart company focused on developing innovative & durable health...

Post Ipo Equity
120 employees
Biotechnology, Health Care
Cardiawave vs

Aortic regurgitation is different. So is our valve.

Series C
149 employees
Health Care, Manufacturing

FAQ About Cardiawave

Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis.
Cardiawave was founded in 2014.
Cardiawave is headquartered in France.
Cardiawave operates in the following industries: Health Care, Medical Devices.
Cardiawave has approximately 33 employees.
Cardiawave has completed 6 funding rounds, raising a total of $13.31M. The latest funding stage is Grant.
Top alternatives and competitors to Cardiawave include Thubrikar Aortic Valve, Anteris Technologies, JenaValve Technology, Inc., Open Medscience , CoreValve. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardiawave and Thubrikar Aortic Valve are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cardiawave and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy